Showing results (431-440 of 548) with videos related to

Sort By:
Pageof 55
JCO Oncology Practice|December 6, 2024
Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research AgendaBryan Valcarcel, Kerry J Savage, Brian K Link, et al.
Nature Neuroscience|November 23, 2023
A dynamic sequence of visual processing initiated by gaze shiftsPhilip R L Parker, Dylan M Martins, Emmalyn S P Leonard, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myelomaTomer Mark, Jessica Stern, Jessica R Furst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Outcome of deferred initial therapy in mantle-cell lymphomaPeter Martin, Amy Chadburn, Paul Christos, et al.
Radiology|July 14, 2006
In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticlePanos P Fatouros, Frank D Corwin, Zhi-Jian Chen, et al.
Blood|November 18, 2018
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Xiaoyu Qu, Hongli Li, Rita M Braziel, et al.
Blood|February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative studyEric D Hsi, Hongli Li, Andrew B Nixon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2007
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphomaJ P Leonard, J W Friedberg, A Younes, et al.
Cancer|November 2, 2023
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017Shoshana M Rosenberg, Shaylene McCue, Jun He, et al.
Pageof 55